Publication | Open Access
<scp>COVID</scp>‐19 antibody screening with <scp>SARS‐CoV</scp>‐2 red cell kodecytes using routine serologic diagnostic platforms
19
Citations
25
References
2021
Year
C19-kodecytes are viable for use as serologic reagent red cells for the detection of SARS-CoV-2 antibody with routine blood antibody screening equipment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1